Noradrenalina B. Braun (Noradrenaline Tartrate)

• Noradrenalina B. Braun is used in critical care settings to manage severe hypotension and shock states.
• Acute hypotension: restores arterial pressure by inducing peripheral vasoconstriction.
• Septic shock: supports circulatory function and organ perfusion during systemic infection.
• Cardiogenic shock: enhances cardiac output while maintaining systemic vascular resistance.
• Cardiac arrest: provides immediate pressor support to facilitate resuscitation efforts.

• Norepinephrine acts primarily as an alpha‑1 adrenergic receptor agonist, producing potent vasoconstriction that raises systemic vascular resistance and arterial pressure. It also stimulates beta‑1 receptors in the heart, modestly increasing myocardial contractility and heart rate, thereby improving cardiac output in shock states.

Administration of norepinephrine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Headache: transient discomfort due to rapid blood pressure changes.
• Tachycardia: increased heart rate secondary to beta‑1 stimulation.
• Peripheral ischemia: reduced blood flow to extremities causing coldness or discoloration.
• Nausea: gastrointestinal upset often related to catecholamine surge.

Serious or Rare Side Effects

• Severe hypertension: excessive rise in blood pressure that may precipitate stroke.
• Myocardial ischemia: reduced coronary perfusion leading to chest pain or infarction.
• Tissue necrosis: extravasation of the drug causing local tissue damage.
• Life‑threatening arrhythmias: abnormal heart rhythms that can progress to cardiac arrest.

• When using Noradrenalina B. Braun, clinicians should observe several safety considerations to minimize risk.
• Dose titration: adjust infusion rate to achieve target blood pressure while avoiding overshoot.
• Cardiac monitoring: continuous ECG and hemodynamic monitoring are required during infusion.
• Extravasation risk: monitor the infusion site closely and discontinue if infiltration is suspected.
• Concomitant drugs: evaluate interactions with MAO inhibitors, beta‑blockers, and other vasopressors.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norepinephrine can interact with other medications, influencing its efficacy or safety profile.

Major Interactions (Avoid)

• MAO inhibitors: may precipitate hypertensive crisis.
• Tricyclic antidepressants: additive pressor effect increasing risk of severe hypertension.
• Beta‑blockers: can blunt the desired increase in heart rate and cardiac output.

Moderate Interactions (Monitor Closely)

• Vasodilators (e.g., nitroglycerin): may reduce the pressor effect of norepinephrine.
• Calcium channel blockers: can alter vascular tone and affect blood pressure response.
• Anesthetic agents (e.g., halothane): may potentiate hypotension and require careful dose adjustment.